Prensa

Cobertura de prensa

Titulares sobre las empresas que clasificamos, recopilados de fuentes de noticias públicas. Enlazamos al artículo original y no lo republicamos — las etiquetas de sentimiento se basan en palabras clave, no en juicio editorial.

Mostrando cobertura para Allergan Aesthetics

27 titulares · 1,721 empresas cubiertas

1–27 de 27

2026-10-17
AbbVie’s Dividend Keeps Climbing. Is It Still a Buy for Income Investors?
Allergan Aesthetics· 247wallst.com
2026-10-17
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
Allergan Aesthetics· fool.com
2026-10-17
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
Allergan Aesthetics· finance.yahoo.com
2026-10-17
What AbbVie (ABBV)'s Phase 3 Lymphoma Win Means For Shareholders
Allergan Aesthetics· finance.yahoo.com
2026-10-17
What Was Eli Lilly Telling You Before Its Stock Ran?
Allergan Aesthetics· trefis.com
2026-10-17
When Amgen's Forecast And Chart Say The Same Thing, Pay Attention
Allergan Aesthetics· trefis.com
2026-10-17
Gilead’s HIV Prevention Business Just Topped $1 Billion A Quarter. What Comes Next?
Allergan Aesthetics· trefis.com
2026-10-17
Is Amgen Stock Increasing Your Market Risk?
Allergan Aesthetics· trefis.com
2026-10-16
Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends
Allergan Aesthetics· fool.com
2026-10-16
AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years
Allergan Aesthetics· tikr.com
2026-10-16
Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?
Allergan Aesthetics· finance.yahoo.com
2026-10-16
AbbVie vs. Merck: Which Pharma Stock Offers Better Value?
Allergan Aesthetics· finance.yahoo.com
2026-10-16
AbbVie is Outperforming the Market this Year So Far. Is Its 16.4x Valuation Attractive?
Allergan Aesthetics· finance.yahoo.com
2026-10-16
5 Stock Ideas for Your Short List
Allergan Aesthetics· finance.yahoo.com
2026-10-15
AbbVie (ABBV) Stock Could Be 44% Undervalued As Cancer Trial News Lands
Allergan Aesthetics· finance.yahoo.com
2026-10-15
What Does AbbVie (ABBV) 51% DLBCL Risk Reduction Mean For Its Oncology Push?
Allergan Aesthetics· finance.yahoo.com
2026-10-15
Gilead and Cardinal Health Stocks Jump to Record Highs. Why Healthcare Is on a Tear.
Allergan Aesthetics· finance.yahoo.com
2026-10-15
How Has Merck's Story Changed?
Allergan Aesthetics· trefis.com
2026-10-15
Cathie Wood-Backed Biotech IPO Pops in Debut
Allergan Aesthetics· finance.yahoo.com
2026-09-30
Allergan brings skin longevity into the GLP-1 era - Longevity.Technology
Allergan Aesthetics· longevity.technology
2026-09-25
Allergan Aesthetics - WCIV
Allergan Aesthetics· abcnews4.com
2026-09-22
Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach - PR Newswire
Allergan Aesthetics· www.prnewswire.com
2026-09-17
Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications - Yahoo Finance
Allergan Aesthetics· finance.yahoo.com
2026-08-11
Allergan Aesthetics Hits Refresh on Allergan Partner Privileges Loyalty Program - The Dermatology Digest
Allergan Aesthetics· thedermdigest.com
2026-08-11
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices - Investing News Network
Allergan Aesthetics· investingnews.com
2026-07-08
Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event - Fierce Pharma
Allergan Aesthetics· www.fiercepharma.com
2026-06-10
Allergan Aesthetics Releases 'The Aesthetics Evolution: What Consumers Really Want' Highlighting Consumer Motivations and Expectations in Aesthetics - AbbVie News Center
Allergan Aesthetics· news.abbvie.com